Delivery Order 75N93021D00005-75N93024F00001
Award Date
4/1/24
Potential Completion Date
3/31/25
Potential Value
$1.3M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Starks Associates Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Buffalo, NY 14213, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.245 million delivery order contract to Starks Associates Inc. under the Preclinical Services for HIV Therapeutics indefinite-delivery/indefinite-quantity master contract. Starks Associates Inc. will conduct synthesis and acquire batches of compounds for subsequent biological in vitro and in vivo testing in support of preclinical services for HIV therapeutics research. The work will be performed...
This is a federal contract award to Starks Associates Inc., a for-profit subchapter S corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract, valued at $15,287,463.93, is for the resynthesis of therapeutic agents for the treatment of infectious diseases. The contract is a definitive contract with a cost-plus-fixed-fee pricing type and has a completion date of September 15, 2011. The contract is set...
This is a federal contract award to Starks Associates Inc., a for-profit subchapter S corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract is for the "Synthesis of Therapeutic Agents for Treatment of Infectious Diseases" and has a ceiling value of $8,129,171.83. The contract is a definitive contract of the cost-plus-fixed-fee type. Starks Associates Inc. is the prime contractor and has...
This task order funds the guaranteed minimum amount under the prime contractor's Preclinical Services for HIV Therapeutics contract with the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Starks Associates Inc. will provide preclinical services in support of HIV therapeutic development work in Buffalo, New York for $0.00 through May 18, 2021. The underlying multiple award indefinite delivery/indefinite quantity contract vehicle was awarded on a cost-no-fee...
Starks Associates Inc. was awarded a $5,908.72 delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Starks Associates to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services for HIV therapeutics....
This is a federal contract award from the National Cancer Institute (NCI), a division of the National Institutes of Health (NIH), to Starks Associates Inc., a for-profit subchapter S corporation. The $41,242,831.54 cost-plus-fixed-fee contract is for the manufacture of bulk chemical and bulk pharmaceutical ingredients for preclinical and clinical studies. Starks Associates specializes in providing preclinical services for HIV therapeutics research to the National Institute of Allergy and...
This federal contract award, valued at $499,879.67, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for the identification of lead compounds to inhibit HIV, as part of NIAID's broader "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract is a Delivery Order...
This is a $403,478.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization. The contract is for conducting hit-to-lead progression studies on investigational agents for the treatment of HIV. This work will be performed under NIAID's Preclinical Services for HIV Therapeutics indefinite...
This federal contract award is for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The prime contractor is Southern Research Institute, a non-profit organization that provides advanced technologies and contract research services, including drug discovery and development, emerging infectious disease research, medicinal chemistry, and toxicology. The contract, with a potential value of $494,934.25, is...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The $999,976 cost-plus-fixed-fee contract is for services to identify inhibitors of HIV-1 capsid dimerization as part of NIAID's In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides program. The contract has no set-aside designation and is...